248 results
Posted on 30.06.2009
NHS CEO has a remedy for the future
An interesting article in the latest issue of Clinica. David Nicolson, the CEO of the UK’s National Health Service (NHS) speaking at the Innovation Expo meeting stressed the importance of investing in innovation for long-term benefits and warned the NHS against isolating itself and becoming risk-averse.Clearly the what Eucomed has been alerting policy makers to […]
Posted on 25.06.2009
Achieving health improvements inside and outside the boardroom
A crowded room at the offices of the European Policy Center yesterday afternoon. The topic of the day is “The future of medical devices in Europe”. The distinguished panel includes Josée Hansen, Pharm. D, project leader, Priority Medical Devices/ EHT, WHO-Geneva . Ms Hansen elaborated on the project’s approach, scope and objectives. In a nutshell, […]
Posted on 27.05.2009
Opening ceremony of Germany’s largest health policy conference, Hauptstadtkongress
Sitting in the crowded main conference hall of Berlin International Congress Center (ICC) on the opening day of Germany’s largest health policy conference, the so-called Hauptstadtkongress, I am keen to see where senior government officials see the healthcare system headed. The conference center breathes the atmosphere of a 70s sci-fi movie. I am listening to […]
An Excellent 12th GHTF Conference explores answers on the future of the GHTF
Just sitting at the airport after what was an excellent Global Harmonization Task Force Conference. Well done Steve Dibert and his crew, not to mention Health Canada. Who says regulatory affairs is boring! This conference really put the moose among the pigeons! We had a truly gripping opening session from Dr. Robert Jackson, the renowned […]
The role of EMEA in future regulation: consensus amongst experts
It was with some trepidation that I placed myself in the ‘lions den’ of the pharmaceutical industry at the annual Euromeeting of the Drug Information Association in Berlin today. Sharing a platform to discuss the evolution of medical device regulation with Mdme Georgette Lalis of the EU Commission and David Feigal, former FDA Commissioner, proved […]